Aurelie Perrin

Dr. Aurelie Perrin

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2024 in Molecules
Verified
Journal Article
Open access
PDF file
CCCamille Colin
Camille Colin
EAEmma Akpo
Emma Akpo
APAurelie Perrin
Aurelie Perrin
DCDavid Cornu
David Cornu
JCJulien Cambedouzou
Julien Cambedouzou
This review aims to gather the current state of the art on the encapsulation methods using alginate as the main polymeric material in order to produce hydrogels ranging from the microscopic to macroscopic sizes. The use of alginates as an encapsulation material is of growing interest, as it is fully bio-based, bio-compatible and bio-degradable. The field of application of alginate encapsulation is also extremely broad, and there is no doubt it will become even broader in the near future considering the societal demand for sustainable materials in technological applications. In this review, alginate’s main properties and gelification mechanisms, as well as some factors influencing this mechanism, such as the nature of the reticulation cations, are first investigated. Then, the capacity of alginate gels to release matter in a controlled way, from small molecules to micrometric compounds, is reported and discussed. The existing techniques used to produce alginates beads, from the laboratory scale to the industrial one, are further described, with a consideration of the pros and cons with each techniques. Finally, two examples of applications of alginate materials are highlighted as representative case studies.

1 May 2004 in Veterinary Research
Verified
Journal Article
Open access
PDF file
CCCatherine Cêtre-Sossah
Catherine Cêtre-Sossah
TBThierry Baldet
Thierry Baldet
JDJean-Claude Delécolle
Jean-Claude Delécolle
BMBruno Mathieu
Bruno Mathieu
APAurelie Perrin
Aurelie Perrin
EAEmmanuel Albina
Emmanuel Albina
Veterinary Research, a journal on Animal Infection

1 September 2007 in Vaccine
Verified
Journal Article
Closed access
APAurelie Perrin
Aurelie Perrin
EAEmmanuel Albina
Emmanuel Albina
EBEmmanuel Bréard
Emmanuel Bréard
CSCorinne Sailleau
Corinne Sailleau
SPSylvie Promé
Sylvie Promé
CCCatherine Cêtre-Sossah
Catherine Cêtre-Sossah

31 March 2006 in Medical and Veterinary Entomology
Verified
Journal Article
Closed access
PDF file
APAurelie Perrin
Aurelie Perrin
CCC. Cetre‐Sossah
C. Cetre‐Sossah
BMB. Mathieu
B. Mathieu
TBT. Baldet
T. Baldet
JDJ.‐C. Delecolle
J.‐C. Delecolle
EAE. Albina
E. Albina

6 June 2024 in Materials
Verified
Journal Article
Open access
PDF file
EAEmma Akpo
Emma Akpo
CCCamille Colin
Camille Colin
APAurelie Perrin
Aurelie Perrin
JCJulien Cambedouzou
Julien Cambedouzou
DCDavid Cornu
David Cornu
Already used in the food, pharmaceutical, cosmetic, and agrochemical industries, encapsulation is a strategy used to protect active ingredients from external degradation factors and to control their release kinetics. Various encapsulation techniques have been studied, both to optimise the level of protection with respect to the nature of the aggressor and to favour a release mechanism between diffusion of the active compounds and degradation of the barrier material. Biopolymers are of particular interest as wall materials because of their biocompatibility, biodegradability, and non-toxicity. By forming a stable hydrogel around the drug, they provide a ‘smart’ barrier whose behaviour can change in response to environmental conditions. After a comprehensive description of the concept of encapsulation and the main technologies used to achieve encapsulation, including micro- and nano-gels, the mechanisms of controlled release of active compounds are presented. A panorama of natural polymers as wall materials is then presented, highlighting the main results associated with each polymer and attempting to identify the most cost-effective and suitable methods in terms of the encapsulated drug.

29 October 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
APAurelie Perrin
Aurelie Perrin
AGAnne-Sophie Gosselin-Grenet
Anne-Sophie Gosselin-Grenet
MRMarie Rossignol
Marie Rossignol
CGCarole Ginibre
Carole Ginibre
BSBethsabée Scheid
Bethsabée Scheid
JBJérémy Bouyer
Jérémy Bouyer
UrbanAedesmosquitoes are vectors of many viruses affecting human health such as dengue, chikungunya and Zika viruses. Insecticide resistance and environmental toxicity risks hamper the effectiveness of chemical control against these mosquito vectors. Alternative control methods, such as the use of mosquito-specific entomopathogenic viruses should be explored. Numerous studies have focused on evaluating the potential of different densoviruses species as biological control agents. However, knowledge on the extent of inter- and intra-specific variations in the susceptibility ofAedesmosquitoes to infection by different densoviruses remains insufficient. In this study, we compared infection and mortality rates induced by theAedes albopictusdensovirus 2 in different strains ofAedes albopictusandAedes aegyptimosquitoes. The twoAedesspecies were different in terms of susceptibility to viral infection. Under laboratory conditions, Aedes albopictus densovirus 2 appeared more virulent for the different strains ofAedes aegyptitested than for those ofAedes albopictus. In addition, we also found significant intra-specific variation in infection and mortality rates. Thus, although even if Aedes albopictus densoviruses could be powerful biocontrol agents used in the management of urbanAedespopulations, our results also call into question the use of single viral isolate as biocontrol agents.